Phase I Pharmacokinetic and Pharmacodynamic Study of Pazopanib in Children With Soft Tissue Sarcoma and Other Refractory Solid Tumors: A Children's Oncology Group Phase I Consortium Report

PURPOSE: Pazopanib, an oral multikinase angiogenesis inhibitor, prolongs progression-free survival in adults with soft tissue sarcoma (STS). A phase I pharmacokinetic and pharmacodynamic study of two formulations of pazopanib was performed in children with STS or other refractory solid tumors. PATIE...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Glade Bender, Julia L., Lee, Alice, Reid, Joel M., Baruchel, Sylvain, Roberts, Timothy, Voss, Stephan D., Wu, Bing, Ahern, Charlotte H., Ingle, Ashish M., Harris, Pamela, Weigel, Brenda J., Blaney, Susan M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2013
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3739862/
https://ncbi.nlm.nih.gov/pubmed/23857966
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2012.47.0914
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados